Each tablet contains Mebhydrolin Napadisylate INN 76 mg equivalent to Mebhydrolin 50 mg.
Mebhydrolin diminishes or abolishes the main actions of histamine in the body by blocking of histamine receptors.
Allergic disease or symptoms such as urticaria, pruritus of various origin, eczema, itching, drug rash, insect bites, allergic conjunctivitis, dermatitis of nutritional origin, hay fever, vasomotor rhinitis, allergic asthma.
Dosage & Administration
Adults and children over 10 years: 2-6 tablets daily
Children 5-10 years: 2-4 tablets daily
Children 2-5 years: 1-3 tablets daily
Children upto 2 years: 1-2 tablets daily
Treatment should be given in several single doses daily. Mebhydrolin may be swallowed during or shortly after meals. For children, the tablet may be crushed and mixed with food.
Lassitude, dizziness, hypotension, muscular weakness, nausea, vomiting, diarrhoea or constipation, epigastric pain, headache, blurred vision, tinnitus, depression, nightmares, anorexia, dryness of the mouth, tightness of the chest, tingling, sedation, drowsiness etc. may occur.
The substance may cause drowsiness, if affected, driving or operating machinery & alcoholic drinks should be avoided.
Hypersensitivity to any of the ingredients of Mebhydrolin tablet or to mebhydrolin
Prostatic hypertrophy, narrow-angle glaucoma
First trimester of pregnancy
Use in Pregnancy & Lactation
Safety in pregnancy and lactation has not been established.
Each box contains 10 blister strips of 10 tablets.